These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9779696)

  • 1. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
    Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
    J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.
    Citron ML; Kaplan R; Parris WC; Croghan MK; Herbst LH; Rosenbluth RJ; Reder RF; Slagle NS; Buckley BJ; Kaiko RF
    Cancer Invest; 1998; 16(8):562-71. PubMed ID: 9844616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
    Parris WC; Johnson BW; Croghan MK; Moore MR; Khojasteh A; Reder RF; Kaiko RF; Buckley BJ
    J Pain Symptom Manage; 1998 Oct; 16(4):205-11. PubMed ID: 9803047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.
    Hale ME; Fleischmann R; Salzman R; Wild J; Iwan T; Swanton RE; Kaiko RF; Lacouture PG
    Clin J Pain; 1999 Sep; 15(3):179-83. PubMed ID: 10524470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients.
    Stambaugh JE; Reder RF; Stambaugh MD; Stambaugh H; Davis M
    J Clin Pharmacol; 2001 May; 41(5):500-6. PubMed ID: 11361046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study.
    Yu S; Shen W; Yu L; Hou Y; Han J; Richards HM
    J Pain; 2014 Aug; 15(8):835-44. PubMed ID: 24846822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
    Mandema JW; Kaiko RF; Oshlack B; Reder RF; Stanski DR
    Br J Clin Pharmacol; 1996 Dec; 42(6):747-56. PubMed ID: 8971431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.
    Caldwell JR; Hale ME; Boyd RE; Hague JM; Iwan T; Shi M; Lacouture PG
    J Rheumatol; 1999 Apr; 26(4):862-9. PubMed ID: 10229408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?
    Salzman RT; Roberts MS; Wild J; Fabian C; Reder RF; Goldenheim PD
    J Pain Symptom Manage; 1999 Oct; 18(4):271-9. PubMed ID: 10534967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.
    Gimbel JS; Richards P; Portenoy RK
    Neurology; 2003 Mar; 60(6):927-34. PubMed ID: 12654955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study.
    Gabrail NY; Dvergsten C; Ahdieh H
    Curr Med Res Opin; 2004 Jun; 20(6):911-8. PubMed ID: 15200750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled-release oxycodone and morphine in cancer related pain.
    Heiskanen T; Kalso E
    Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.
    Silvestri B; Bandieri E; Del Prete S; Ianniello GP; Micheletto G; Dambrosio M; Sabbatini G; Endrizzi L; Marra A; Aitini E; Calorio A; Garetto F; Nastasi G; Piantedosi F; Sidoti V; Spanu P
    Clin Drug Investig; 2008; 28(7):399-407. PubMed ID: 18544000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.